ArticleJMIR formative research2025
Deep Learning for the Early Detection of Invasive Ductal Carcinoma in Histopathological Images: Convolutional Neural Network Approach With Transfer Learning.
Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reducing false positives in breast cancer screening with computer-aided detection.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInvasive ductal carcinoma (IDC) is considered the most common form of breast cancer, accounting for a significant percentage of mortality worldwide. Therefore, its early detection is vital to further improve patients' outcomes and survival rates. However, conventional diagnostic methods in the form of manual histopathological examinations are time-consuming, subjective, and prone to errors. Therefore, there is an urgent need to develop automated solutions for accurate IDC detection in histopathology images to assist pathologists in clinical decision-making.
objectiveWe aim to develop and validate a convolutional neural network (CNN) model for early detection of IDC by analyzing histopathological images. The specific objectives are designing a deep learning-based technique for automated detection of IDC, assessing its performance compared to traditional diagnostic methods, and evaluating its utility in a clinical setup for early breast cancer diagnosis. These methods will be available to practitioners in underdeveloped countries via an open-source application.
methodsThe dataset for the research included 277,524 publicly available histopathological images from Kaggle, comprising both IDC-positive and IDC-negative images. About 71.6% of images were IDC-positive (class 0), while 28.4% were IDC-negative (class 1). Since our data are unbalanced, we created a weighted loss function to overcome the class imbalance problem. Further development was based on a CNN using the approach of transfer learning with a pretrained architecture called Visual Geometry Group to uplift feature extraction so that performance may improve; hence, images were preprocessed and normalized to perform augmentation with robustness. The model was developed using a split of 80% for training and 20% for testing. Model performance was measured for accuracy, sensitivity, specificity, precision, recall, and F
resultsFrom our CNN base model, we obtained an accuracy of 89% on the test set. Later, the base model was used with a weighted loss function to balance the class weights, giving a lower accuracy of 86% on the test set. Data augmentation was performed but did not improve the results. To deal with the class imbalance effectively, we performed transfer learning with a pretrained model, which gave an accuracy of 90% on the test set.
conclusionsThe CNN-based model thus showed accuracy and reliability for early detection of IDC from histopathological images. This technique will potentially act as an efficient and accurate assistant tool for pathologists, contributing to the early diagnosis of breast cancer and improving clinical outcomes. This paper provides an important contribution toward refining the performance of this model and widening its applications in a clinical setting by integrating it with other diagnostic techniques for better outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.